http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007033515-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f31ebbe4d87943109630680beb34f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aeeb5279f5d97e3b6debbe16576fdd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da0f5274b9275593eabfa3cd7cc5b6fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1df702ec6522f541db55001ff66eba4f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2005-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e87443b49403e0948c50103469f4dafa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeb10d2ae65f3cef2a117a9a98ca3d20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba20eadbe7b94c1ecf339231e9f2c1d
publicationDate 2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007033515-A1
titleOfInvention Oral formulation containing moxifloxacin and its preparation method
abstract An oral tablet formulation of moxifloxacin or its salts and/or hydrates, comprises at least one film-forming material used for coating the intermediate particles. Said film-forming material may be one or more of hydroxypropyl methylcellulose, hydroxyethyl methylcellulose, methylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, sodium carboxymethycellulose, polyacrylic resins, polyethylene glycol, polyvinylpyrrolidone vinylacetate copolymer, PVA-PEG graft copolymer, carbopol, gelatin, poloxamer, polyvinylpyrrolidone. Preparation of said formulation comprises: mixing or granulating moxifloxacin blended with excipients, coating the intermediate granular with the film- forming material, then compressing the mixture. The invented tablet formulation has a prolonged shelf life and rapid dissolution.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021186885-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110882281-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102247313-A
priorityDate 2005-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005020998-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136293705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412489

Total number of triples: 28.